These are the stocks posting the largest moves before the bell.Market Insiderread more
Target beats second-quarter earnings expectations thanks to an increase in traffic and sales. The retailer also boosts its full-year estimates.Retailread more
Corporate debt recently passed the $1 trillion mark in a continuing sign of global financial displacement.Marketsread more
Trump said he has "been thinking about payroll taxes for a long time" — and he cautioned that "whether or not we do something now, it's not being done because of recession."Politicsread more
Lowe's also tops rival Home Depot on same-store sales growth in the U.S.Retailread more
President Donald Trump said on Twitter he was postponing a scheduled meeting with Denmark's prime minister because of her lack of interest in discussing a possible sale of...World Politicsread more
Dow to open higher; strong retail earnings; Gundlach says Fed lost control; negative-yielding corporate debt soars; and Trump on payroll tax cutMarketsread more
After a rush on refinances, homeowners took a breather last week, despite still seeing the lowest interest rates in about three years.Real Estateread more
Toni Sacconaghi said increased competition abroad is responsible for the weakness in Tesla's sales volume.Investingread more
The growing popularity of cocaine cut with fentanyl — known on the street as a speedball — or combinations of methamphetamine and fentanyl — known as a goofball — are driving...Health and Scienceread more
After Elon Musk touts Tesla solar on Twitter, Walmart sues the electric vehicle and clean energy company over store rooftop panels that ignited.Technologyread more
Walgreens Boots Alliance Inc will pay $269.2 million to settle two U.S. whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs, the U.S. Department of Justice said on Tuesday.
The pharmacy chain will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid and other federal programs for hundreds of thousands of insulin pens it dispensed to patients it knew did not need them.
Walgreens will also pay $60 million to resolve claims it overbilled Medicaid by failing to disclose and charge the lower drug prices it offered the public through a discount program.
The settlements resolve claims under the federal False Claims Act, and were respectively approved last week by U.S. District Judges Paul Crotty and Paul Oetken, who both sit in Manhattan.
Walgreens admitted and accepted responsibility for the alleged wrongdoing, the settlement agreements show.